Inventor · disambiguated record
Sudhir Agrawal
Also filed as: AGRAWAL SUDHIR · AGRAWAL SUDHIR K
153 granted patents·74 pending applications·16,142 citations·filing 1988–2025
99Inventor score
Files withIDERA PHARMACEUTICALS INC84HYBRIDON INC66WORCESTER FOUND EX BIOLOGY13AGRAWAL SUDHIR10KANDIMALLA EKAMBAR8
Top patents by PatentIndex Score
227 records- 0199US5510475AOligonucleotide multiple reporter precursorsHYBRIDON INC·Filed 1994·Granted Apr 23, 1996·853 cites·3 claims
- 0298US8202850B2Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5′ endsAGRAWAL SUDHIR·Filed 2010·Granted Jun 19, 2012·60 cites·17 claims
- 0398US7812000B2Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5′ endsIDERA PHARMACEUTICALS INC·Filed 2007·Granted Oct 12, 2010·66 cites·18 claims
- 0498US7427405B2Immunostimulatory oligonucleotide multimersIDERA PHARMACEUTICALS INC·Filed 2005·Granted Sep 23, 2008·40 cites·7 claims
- 0598US7276489B2Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5′ endsIDERA PHARMACEUTICALS INC·Filed 2002·Granted Oct 2, 2007·221 cites·22 claims
- 0698US6683167B2Hybrid oligonucleotide phosphorothioatesUNIV MASSACHUSETTS WORCESTER·Filed 2001·Granted Jan 27, 2004·311 cites·17 claims
- 0798US6608035B1Method of down-regulating gene expressionHYBRIDON INC·Filed 2000·Granted Aug 19, 2003·279 cites·2 claims
- 0898US6476000B1Modulation of oligonucleotide CpG-mediated immune stimulation by positional modification of nucleosidesHYBRIDON INC·Filed 2000·Granted Nov 5, 2002·156 cites·6 claims
- 0998US6383752B1Pseudo-cyclic oligonucleobasesHYBRIDON INC·Filed 2000·Granted May 7, 2002·200 cites·33 claims
- 1098US6346614B1Hybrid oligonucleotide phosphorothioatesHYBRIDON INC·Filed 2000·Granted Feb 12, 2002·381 cites·15 claims
- 1198US5652356AInverted chimeric and hybrid oligonucleotidesHYBRIDON INC·Filed 1995·Granted Jul 29, 1997·603 cites·2 claims
- 1298US5652355AHybrid oligonucleotide phosphorothioatesWORCESTER FOUND EX BIOLOGY·Filed 1992·Granted Jul 29, 1997·833 cites·12 claims
- 1398US5563253ALinear aminoalkylphosphoramidate oligonucleotide derivativesWORCESTER FOUND EX BIOLOGY·Filed 1994·Granted Oct 8, 1996·1.2k cites·2 claims
- 1498US5536821AAminoalkylphosphorothioamidate oligonucleotide derativesWORCESTER FOUND EX BIOLOGY·Filed 1994·Granted Jul 16, 1996·1.3k cites·2 claims
- 1598US5366878AMethod of site-specific alteration of RNA and production of encoded polypeptidesWORCESTER FOUND EX BIOLOGY·Filed 1993·Granted Nov 22, 1994·871 cites·1 claims
- 1697US7566702B2Immunostimulatory oligonucleotide multimersIDERA PHARMACEUTICALS INC·Filed 2005·Granted Jul 28, 2009·28 cites·7 claims
- 1797US7498425B2Immunostimulatory oligonucleotide multimersIDERA PHARMACEUTICALS INC·Filed 2005·Granted Mar 3, 2009·28 cites·7 claims
- 1897US7498426B2Immunostimulatory oligonucleotide multimersIDERA PHARMACEUTICALS INC·Filed 2005·Granted Mar 3, 2009·28 cites·7 claims
- 1997US5591721AMethod of down-regulating gene expressionHYBRIDON INC·Filed 1994·Granted Jan 7, 1997·426 cites·1 claims
- 2097US5541306AAminoalkylphosphotriester oligonucleotide derivativesWORCESTER FOUND EX BIOLOGY·Filed 1994·Granted Jul 30, 1996·1.1k cites·2 claims
- 2197US5149797AMethod of site-specific alteration of rna and production of encoded polypeptidesWORCESTER FOUND EX BIOLOGY·Filed 1990·Granted Sep 22, 1992·767 cites·5 claims
- 2296US9453228B2Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune responseIDERA PHARMACEUTICALS INC·Filed 2015·Granted Sep 27, 2016·21 cites·24 claims
- 2396US8431544B1Compositions for inhibiting gene expression and uses thereofAGRAWAL SUDHIR·Filed 2010·Granted Apr 30, 2013·48 cites·16 claims
- 2496US7517862B2Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5′ endsIDERA PHARMACEUTICALS INC·Filed 2004·Granted Apr 14, 2009·64 cites·9 claims
- 2596US7470674B2Immunostimulatory properties of oligonucleotide-based compounds comprising modified immunostimulatory dinucleotidesIDERA PHARMACEUTICALS INC·Filed 2005·Granted Dec 30, 2008·48 cites·19 claims
- 2696US7045609B2Hybrid oligonucleotide phosphorothioatesUNIV MASSACHUSETTS WORCESTER·Filed 2002·Granted May 16, 2006·67 cites·16 claims
- 2796US6936593B1Method of down-regulating gene expressionHYBRIDON INC·Filed 2001·Granted Aug 30, 2005·111 cites·20 claims
- 2896US6426334B1Oligonucleotide mediated specific cytokine induction and reduction of tumor growth in a mammalHYBRIDON INC·Filed 1997·Granted Jul 30, 2002·210 cites·1 claims
- 2996US5886165AMixed backbone antisense oligonucleotides containing 2'-5'-ribonucleotide- and 3'-5'-deoxyribonucleotides segmentsHYBRIDON INC·Filed 1996·Granted Mar 23, 1999·206 cites·15 claims
- 3096US5856462AOligonucleotides having modified CpG dinucleosidesHYBRIDON INC·Filed 1996·Granted Jan 5, 1999·231 cites·7 claims
- 3196US5220007AMethod of site-specific alteration of RNA and production of encoded polypeptidesWORCESTER FOUND EX BIOLOGY·Filed 1992·Granted Jun 15, 1993·661 cites·12 claims
- 3295US10463686B2Immune modulation with TLR9 agonists for cancer treatmentIDERA PHARMACEUTICALS INC·Filed 2017·Granted Nov 5, 2019·6 cites·24 claims
- 3395US7407944B2Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5′ endsIDERA PHARMACEUTICALS INC·Filed 2004·Granted Aug 5, 2008·56 cites·6 claims
- 3495US7405285B2Immunostimulatory oligonucleotide multimersIDERA PHARMACEUTICALS INC·Filed 2005·Granted Jul 29, 2008·35 cites·7 claims
- 3595US7105495B2Modulation of oligonucleotide CpG-mediated immune stimulation by positional modification of nucleosidesIDERA PHARMACEUTICALS INC·Filed 2003·Granted Sep 12, 2006·48 cites·3 claims
- 3695US6815429B2Modulation of oligonucleotide CpG-mediated immune stimulation by positional modification of nucleosidesHYBRIDON INC·Filed 2001·Granted Nov 9, 2004·53 cites·8 claims
- 3795US5149798AProcess for synthesizing oligonucleotides and their analogs adaptable to large scale synthesesWORCESTER FOUND EX BIOLOGY·Filed 1989·Granted Sep 22, 1992·113 cites·2 claims
- 3894US8426375B2Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune responseKANDIMALLA EKAMBAR·Filed 2008·Granted Apr 23, 2013·25 cites·15 claims
- 3994US7709617B2Synergistic stimulation of the immune system using immunostimulatory oligonucleotides and/or immunomer compounds in conjunction with cytokines and/or chemotherapeutic agents or radiation therapyIDERA PHARMACEUTICALS INC·Filed 2005·Granted May 4, 2010·18 cites·7 claims
- 4094US7262286B2Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changesIDERA PHARMACEUTICALS INC·Filed 2001·Granted Aug 28, 2007·42 cites·5 claims
- 4194US7176296B2Modulation of oligonucleotide CpG-mediated immune stimulation by positional modification of nucleosidesIDERA PHARMACEUTICALS INC·Filed 2003·Granted Feb 13, 2007·52 cites·4 claims
- 4294US5968909AMethod of modulating gene expression with reduced immunostimulatory responseHYBRIDON INC·Filed 1995·Granted Oct 19, 1999·148 cites·19 claims
- 4394US5773601AInverted chimeric and hybrid oligonucleotidesHYBRIDON INC·Filed 1997·Granted Jun 30, 1998·123 cites·2 claims
- 4494US5321131ASite-specific functionalization of oligodeoxynucleotides for non-radioactive labellingHYBRIDON INC·Filed 1990·Granted Jun 14, 1994·1.3k cites·1 claims
- 4593US7632822B2Modulation of immunostimulatory properties of oligonucleotide-based compounds by utilizing modified immunostimulatory dinucleotidesIDERA PHARMACEUTICALS INC·Filed 2005·Granted Dec 15, 2009·17 cites·7 claims
- 4693US5693773ATriplex-forming antisense oligonucleotides having abasic linkers targeting nucleic acids comprising mixed sequences of purines and pyrimidinesHYBRIDON INC·Filed 1995·Granted Dec 2, 1997·118 cites·14 claims
- 4792US8399423B2Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune responseKANDIMALLA EKAMBAR·Filed 2008·Granted Mar 19, 2013·12 cites·12 claims
- 4892US8383598B2Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune responseIDERA PHARMACEUTICALS INC·Filed 2008·Granted Feb 26, 2013·12 cites·13 claims
- 4992US8008267B2Stabilized immunomodulatory oligonucleotidesIDERA PHARMACEUTICALS INC·Filed 2004·Granted Aug 30, 2011·29 cites·16 claims
- 5092US7960362B2Synthetic agonists of TLR9IDERA PHARMACEUTICALS INC·Filed 2008·Granted Jun 14, 2011·19 cites·6 claims
Showing the top 50 of 227 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Sudhir Agrawal files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →